Premium
Waldenström macroglobulinemia: A review of therapy
Author(s) -
Gertz Morie A.
Publication year - 2005
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.20363
Subject(s) - lymphoplasmacytic lymphoma , waldenstrom macroglobulinemia , macroglobulinemia , medicine , lymphoma , monoclonal gammopathy , intensive care medicine , dermatology , monoclonal , immunology , multiple myeloma , antibody , monoclonal antibody
Waldenström macroglobulinemia is a rare monoclonal gammopathy‐associated lymphoplasmacytic lymphoma. Its incidence is only 4 per million per year. This review contains the known published literature specifically on the available management tools for Waldenström macroglobulinemia and is designed to assist clinicians in making management decisions for patients with this uncommon disorder. Am. J. Hematol. 79:147–157, 2005. © 2005 Wiley‐Liss, Inc.